The purpose of this study was to reveal the effect of electroacupoint on scanty milk production in lactating women.

Postnatal scanty milk secretion is a common complaint. Some physical and medicinal therapies have been proposed to enhance milk production. These therapies must be both successful and safe for both the mother and the child. In many cases, milk supply can be increased by frequent, regular milk removal, Medication to increase milk supply (galactogogues) such as domperidone.

Domperidone has been linked to maternal adverse effects in galactogogue trials and cases reported to the Food and Drug Administration include dry mouth, headache, dizziness, nausea, abdominal cramping, diarrhea, palpitations malaise, and shortness of breath. Some of these were more frequent with dosages greater than with 30 mg daily. Drug withdrawal symptoms consisting of insomnia, anxiety, and tachycardia were reported in a woman taking 80 mg of domperidone daily for 8 months as a galactogogue who abruptly tapered the dose over 3 days.

Inclusion Criteria:

• They were complaining of insufficiency of lactation within the first month after cesarean section.
• They are using mixed feeding; both breast and bottle feeding, between three and six bottles per day.
• Their age ranged from 25-30 years old.
• Their body mass index didn't exceeded 30 kg/m2.

Exclusion Criteria:

• Postpartum haemorrhage.
• Cardiorespiratory disease.
• Diabetes mellitus.
• Breast cancer.
• Previous surgeries in the chest, breast, or the surrounding area.
• Anemia.
• Any causes that hindered their normal breastfeeding (retraced, cracked, inflamed, or inverted nipples).
• Receiving contraceptive pills.
• Having infants with conditions that may affect the lactation process such as congenital abnormalities of the mouth (tongue tie, cleft palate).
• Congenital heart disease.

This study is specified for Females who have diminutive milk production.